Epsilon Pharmaceuticals

Hyderabad, India Founded: 2010 • Age: 16 yrs Acquired By Amneal
Generic oncology pharmaceuticals are manufactured on a contract basis.

About Epsilon Pharmaceuticals

Epsilon Pharmaceuticals was founded in 2010 and is headquartered in Hyderabad, India. Operations center on the oncology sector, where generic pharmaceuticals are developed in forms including lyophilized powders, liquids, tablets, capsules, and sterile injectables. Contract manufacturing services for prescription drugs are extended to various clients, supporting production needs in this specialized field.

  • Headquarter Hyderabad, India
  • Sectors
    Healthcare
  • Website epsilonpharma.com
  • Social Facebook
  • Acquired by Amneal (Jun 2014)
  • Legal Name Epsilon Pharmaceuticals Pvt Ltd
Key Metrics
  • Annual Revenue
    $14.66 M (USD)
    26
    as on Mar 31, 2024
  • Net Profit
    $1.08 M (USD)
    2
    as on Mar 31, 2024
  • EBITDA
    $2.75 M (USD)
    -4
    as on Mar 31, 2024
  • Investors
  • Acquired by
    Amneal

    (Jun 2014)

Investors in Epsilon Pharmaceuticals

Epsilon Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Amneal.

All
InvestorDescriptionFounded YearDomainLocation
Manufacturer of generics formulations
2002amneal.comBridgewater, United States
Premium access

Investor details for Epsilon Pharmaceuticals

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Epsilon Pharmaceuticals

2 dated milestones of Epsilon Pharmaceuticals across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Epsilon Pharmaceuticals is founded.
  2. Exit Acquired by Amneal.

Similar companies to Epsilon Pharmaceuticals

10 companies that operate in the same segment as Epsilon Pharmaceuticals (Traditional Health & Nutrition), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United States–USD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Oral solid drug delivery systems are manufactured and developed.
1985Mumbai, Maharashtra, IndiaUSD 42.49 MUSD 89.42 M962
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United States–USD 5.1 B13,500
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals.
1901Petah Tikva, Central District, IsraelUSD 500 MUSD 18.74 B51,792
Generic, semi-solid, and liquid dosage forms are manufactured.
1990Bengaluru, Karnataka, India–USD 508.93 M5,180
Pharmaceutical products are developed and marketed globally.
2009Montville, New Jersey, United StatesUSD 155.92 M––
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
1983Mumbai, Maharashtra, India–USD 6.21 B25,870
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations
1991Delhi, Delhi, IndiaUSD 367.2 MUSD 1.52 B21,320
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt.
1967Mumbai, Maharashtra, India–USD 353.53 M3,410
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Epsilon Pharmaceuticals

Epsilon Pharmaceuticals was founded in 2010.

Epsilon Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Annual revenue of Epsilon Pharmaceuticals is $14.66M as on Mar 31, 2024.

Epsilon Pharmaceuticals was founded in 2010 and is headquartered in Hyderabad, India. Operations center on the oncology sector, where generic pharmaceuticals are developed in forms including lyophilized powders, liquids, tablets, capsules, and sterile injectables. Contract manufacturing services for prescription drugs are extended to various clients, supporting production needs in this specialized field.

Epsilon Pharmaceuticals has 1 investor. Key investors include Amneal.

Epsilon Pharmaceuticals operates through Epsilon Pharmaceuticals Pvt Ltd.

Yes. Epsilon Pharmaceuticals was acquired by Amneal in June 2014.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available